Access Capital Closes $5MM Facility for Transformative Pharmaceutical Solutions

Access Capital closed a $5 million facility for Transformative Pharmaceutical Solutions (TPS), a specialized provider of proprietary software solutions for the management and execution of clinical trials to the pharmaceutical industry. The company was founded in 2015 by Daniel Perlman, CEO of the company.

TPS is experiencing an increase in its sales growth and projects continued growth over the next few years. As a means to provide support for this projected growth, Access Capital provided the $5 million facility.  

“TPS is pleased to add Access Capital as a partner. We believe this relationship will help us continue the exceptional growth we are achieving,” Perlman said.